Science
Mechanism of Action
Specific mechanisms of Cinnamoyl Tryptamine acting on the skin are not yet clearly defined in current literature. However, structurally related cinnamoyl alkylamides, such as N-trans-cinnamoyltyramine (NTCT), have been shown to inhibit protein tyrosine kinases, including the epidermal growth factor receptor (EGFR), and to suppress the proliferation of human tumor cells. This suggests a potential role for Cinnamoyl Tryptamine in modulating cellular signaling pathways within the skin.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
The exact stability profile of Cinnamoyl Tryptamine is not detailed in the available data. However, tryptamine alkaloids generally exhibit better stability when stored as dried biomass in the dark at room temperature, as opposed to cold storage.
Safety
Safety Profile
Cinnamoyl Tryptamine has not been reported for use in cosmetic products under the FDA's Voluntary Cosmetics Reporting Program. This typically indicates that the Cosmetic Ingredient Review (CIR) Expert Panel has not identified a need for further safety review at this time.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to a lack of specific clinical data, comprehensive safety assessments, and direct mechanistic details for Cinnamoyl Tryptamine on skin, its overall utility and safety profile remain largely uncharacterized.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources